Alnylam Pharmaceuticals Inc (ALNY)

Industry Biotechnology

This stock can be held in an Investment ISA and an Investment Account

Sell

$296.40

Buy

$306.59

arrow-down$-3.08 (-1.01%)

Prices updated at 30 May 2026, 00:32 EDT

Prices minimum 15 mins delay

Prices in USD

Alnylam Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in developing novel therapeutics based on RNA interference, or RNAi. RNAi is a naturally occurring biological pathway within cells for regulating the expression of specific genes.

NASDAQ

0.2%

NASDAQ

Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and

Our Investment Fees and Charges.

	$305.68 - $297.62
	$495.55 - $284.28
	-
	40,318.13m
	75.87
	-
	2,278,070
	37.49
	1,220,563.70
	0.86
	132.38m
	US02043Q1076
	3.98
	-

Please note that past performance is not a reliable indicator of future returns. Pre-sale Illustration.

Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.